Patent · US Active

Therapeutic indazoles

US11186549B2 · kind B2 · utility

1Cited by

6References

12Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Joel Freundlich · Princeton, US
David Alland · Dobbs Ferry, US
Matthew B. Neiditch · New Brunswick, US
Pradeep Kumar · Johannesburg, ZA
Glenn Capodagli · Denver, US
Divya AWASTHI · Setauket, US
Sean Ekins · Abington, US

Key dates

Filing date	Aug 29, 2018
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Aug 29, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I): and salts thereof wherein R1-R5 have any of the meanings described in the specification. The compounds are useful for treating bacterial infections (e.g. tuberculosis).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.